June 1, 2025

Reopening Of The Call For Applications For The Pilot Phase Of the Joint Evaluation Project Between the Egyptian Drug Authority (EDA) and the South African Health Products Regulatory Authority (SAHPRA)

The Egyptian Drug Authority (EDA) and the South African Health Products Regulatory Authority (SAHPRA) have announced the reopening of their joint pilot project for the collaborative […]
April 10, 2025

Tunisia: Pharmacovigilance, Urgent Deadline For Compliance With Regulation!

Tunisian National Agency for Medicines and Health Products (ANMPS) issued an urgent and important note by 10 April 2025 reminding all pharmaceutical companies to comply with pharmacovigilance […]
February 2, 2025

ALGERIA: Advancing Regulatory Digitalization in the Medical Device Sector

In an effort to enhance efficiency and transparency, the Algerian National Agency for Pharmaceutical Products (ANPP) has introduced key digitalization initiatives for the regulatory processes related […]
January 6, 2025

The International Council for Harmonisation (ICH) Adopts the ICH E6(R3) Guideline

On January 6, 2025, the International Council for Harmonisation (ICH) adopted the ICH E6(R3) Guideline, introducing significant advancements in Good Clinical Practice (GCP). This updated guideline […]
December 5, 2024

Senegal and Rwanda Achieve WHO Maturity Level 3 in Medicines Regulation

Senegal and Rwanda have reached a significant milestone by achieving the World Health Organization’s (WHO) Maturity Level 3 in medicines regulation. This status reflects their capabilities […]